TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34686382

Group type: EXPERIMENTAL
Intervention: Gender congruence and vignette modality (text, audio, video)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Vignette modality (video)
Number of subjects: 209
Study: 33269608

Group type: EXPERIMENTAL
Intervention: Structured intervention on self-care with AVF (SISC-AVF)
Number of subjects: 89
Study: 32831109

Group type: EXPERIMENTAL
Intervention: Bang® Keto Coffee (130 kcal, 300 mg caffeine, 20 g protein)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (30 kcal, 11 mg caffeine, 1 g protein)
Number of subjects: 16
Study: 33249320

Group type: EXPERIMENTAL
Intervention: High intensity resistance exercise (HIT‐RT) for 18 months
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-training control group (CG)
Number of subjects: 43
Study: 35040210

Group type: EXPERIMENTAL
Intervention: nano-curcumin 240 mg/day for 7 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: nano-curcumin
Number of subjects: 60

Group type: COMPARATOR
Intervention: control
Number of subjects: 60
Study: 36092793

Group type: EXPERIMENTAL
Intervention: Multichannel CNN-based eye model
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Doctors' experience and multichannel CNN-based eye model
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (Doctors' experience only)
Number of subjects: 64
Study: 32995832

Group type: EXPERIMENTAL
Intervention: Laser-assisted ICSI (LA-ICSI)
Number of subjects: 966

Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 966
Study: 35809488

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (18 sessions over 12 months)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study: 33473163

Group type: EXPERIMENTAL
Intervention: CTC-driven monitoring
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 204
Study: 32380972

Group type: EXPERIMENTAL
Intervention: eHealth intervention with interactive features
Number of subjects: 0

Group type: COMPARATOR
Intervention: eHealth intervention with static information
Number of subjects: 0
Study: 35655213

Group type: EXPERIMENTAL
Intervention: Integrated breast massage (IBM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional breast massage (TBM)
Number of subjects: 84
Study: 32442198

Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Spontaneous detachment
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Dorsal slit requirement
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 197
Study: 615917691

Group type: EXPERIMENTAL
Intervention: Ranibizumab (RBZ) 0.3 mg or 0.5 mg monthly injections
Number of subjects: 759

Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 759
Study: 33640493

Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg
Number of subjects: 81
Study: 35007113

Group type: EXPERIMENTAL
Intervention: State-funded pre-kindergarten program
Number of subjects: 2990

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 2990
Study: 34323452

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 409

Group type: COMPARATOR
Intervention: Surgical intervention
Number of subjects: 409
Study: 35031340

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard of care (SOC) treatment
Number of subjects: 62
Study: 33447962

Group type: EXPERIMENTAL
Intervention: Severe multiple symptoms
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Urinary incontinence
Number of subjects: 500
Study: 34535938

Group type: EXPERIMENTAL
Intervention: EP-guided cryoballoon ablation (CBA)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional cryoballoon ablation (CBA)
Number of subjects: 136
Study: 33047942

Group type: EXPERIMENTAL
Intervention: LUCAS 3 mechanical CC device
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: TrueCPR feedback device
Number of subjects: 67

Group type: COMPARATOR
Intervention: Manual CCs
Number of subjects: 67
Study: 35700341

Group type: EXPERIMENTAL
Intervention: E2027 (50 to 400 mg single doses)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: E2027 (≥50 mg QD)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: E2027 (50 mg QD)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: E2027 (single and multiple administration)
Number of subjects: 164
Study: 34403019

Group type: EXPERIMENTAL
Intervention: Hypnotic intervention designed to reduce hot flashes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic intervention
Number of subjects: 0
Study: 35397233

Group type: EXPERIMENTAL
Intervention: Laser blepharoplasty
Number of subjects: 145

Group type: COMPARATOR
Intervention: Blade blepharoplasty
Number of subjects: 145
Study: 33433656

Group type: EXPERIMENTAL
Intervention: Integrative oncology treatment program (high adherence, attending ≥4 sessions during the first 6 weeks)
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Integrative oncology treatment program (high adherence)
Number of subjects: 815

Group type: COMPARATOR
Intervention: Integrative oncology treatment program (low adherence)
Number of subjects: 815
Study: 32433835

Group type: EXPERIMENTAL
Intervention: Aripiprazole Lauroxil (AL) - AL NanoCrystal Dispersion + oral aripiprazole 30 mg on day 1; AL 1,064 mg on day 8 and every 8 weeks thereafter
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paliperidone palmitate (PP) - PP 234 mg on day 1; PP 156 mg on day 8 and then every 4 weeks thereafter
Number of subjects: 200
Study: 35991136

Group type: EXPERIMENTAL
Intervention: Ultrasound based on deep learning algorithm (BCNN-S)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional ultrasound
Number of subjects: 80
Study: 32565073

Group type: EXPERIMENTAL
Intervention: 200 mg doxycycline administered within 72 hours after tick removal
Number of subjects: 1689

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 1689

Group type: EXPERIMENTAL
Intervention: 200 mg doxycycline
Number of subjects: 1689
Study: 36164035

Group type: EXPERIMENTAL
Intervention: GDP (gemcitabine, dexamethasone, and cisplatin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: DHAP (dexamethasone, cytarabine, and cisplatin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: GDP
Number of subjects: 100

Group type: COMPARATOR
Intervention: DHAP
Number of subjects: 100
Study: 33781979

Group type: EXPERIMENTAL
Intervention: Vein of Marshall ethanol infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35537216

Group type: EXPERIMENTAL
Intervention: Active intermittent theta-burst stimulation (iTBS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham intermittent theta-burst stimulation (iTBS)
Number of subjects: 42
Study: 32804911

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 943

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 943
Study: 34253805

Group type: EXPERIMENTAL
Intervention: Trifluridine/tipiracil
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: TAS-RECOSMO model
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Colon Life model
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: FAS-CORRECT model
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: RECOURSE model
Number of subjects: 244
Study: 33213514

Group type: EXPERIMENTAL
Intervention: AHT10s (applying hot towels for 10 s to the back)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (wiping only)
Number of subjects: 50
Study: 32845371

Group type: EXPERIMENTAL
Intervention: Strabismus surgery without anterior ciliary vessel preservation (Group A1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Strabismus surgery with anterior ciliary vessel preservation (Group B1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Corresponding nonsurgical eyes (Group A2 and B2)
Number of subjects: 60
Study: 34788486

Group type: EXPERIMENTAL
Intervention: Acute hypoxia
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mixed trial (50 mmHg only during PECO)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 32
Study: 32829304

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI) every 4 weeks (q4wk)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI) every 12 weeks (q12wk)
Number of subjects: 40
Study: 32997826

Group type: EXPERIMENTAL
Intervention: Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for pain on maximum jaw opening
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for pain on palpation
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Combination of pain on maximum jaw opening and pain on palpation using DC/TMD
Number of subjects: 282
Study: 33568585

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet-rich fibrin (T-PRF)
Number of subjects: 140
Study: 35536574

Group type: EXPERIMENTAL
Intervention: Self-Help Plus (SH+) intervention plus enhanced usual care
Number of subjects: 627

Group type: COMPARATOR
Intervention: Enhanced usual care alone
Number of subjects: 627
Study: 34843183

Group type: EXPERIMENTAL
Intervention: Spironolactone (12.5-25-50 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35419729

Group type: EXPERIMENTAL
Intervention: Moxibustion at 43 °C combined with acupuncture
Number of subjects: 63

Group type: COMPARATOR
Intervention: Moxibustion at 37 °C combined with sham acupuncture
Number of subjects: 63
Study: 33904027

Group type: EXPERIMENTAL
Intervention: Potassium citrate (K-CIT) 40 mEq/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 50 mg/day
Number of subjects: 80
Study: 33233328

Group type: EXPERIMENTAL
Intervention: Slackline intervention (3 sessions per week, 30 min/session for 6 weeks)
Number of subjects: 27
Study: 33111647

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Relapse Prevention (RP)
Number of subjects: 79
Study: 32628044

Group type: EXPERIMENTAL
Intervention: OCS Heart System
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33345885

Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone caproate adherence (greater than 80% of intended injections)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone caproate adherence
Number of subjects: 92
Study: 35841414

Group type: EXPERIMENTAL
Intervention: 19‐biomarker model (19‐BM)
Number of subjects: 147

Group type: COMPARATOR
Intervention: PSA
Number of subjects: 147

Group type: COMPARATOR
Intervention: PSA density (PSAD)
Number of subjects: 147

Group type: COMPARATOR
Intervention: ERSPC‐3/4 risk calculator
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Integration of 19‐BM with clinical variables into diagnostic nomograms (DN)
Number of subjects: 147
Study: 32891604

Group type: EXPERIMENTAL
Intervention: Intensive therapy (HbA1c under 6.2%, blood pressure under 120/75 mmHg, low-density lipoprotein cholesterol under 80 mg/dL)
Number of subjects: 2540

Group type: COMPARATOR
Intervention: Conventional therapy (HbA1c under 6.9%, blood pressure under 130/80 mmHg, low-density lipoprotein cholesterol under 120 mg/dL)
Number of subjects: 2540
Study: 34993588

Group type: EXPERIMENTAL
Intervention: No-stent group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Internal-stent group
Number of subjects: 90
Study: 33053431

Group type: EXPERIMENTAL
Intervention: Medical Assistant Health Coaching (MA health coaching)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: MA health coaching
Number of subjects: 600
Study: 32735422

Group type: EXPERIMENTAL
Intervention: IPSI group: rolling the ipsilateral knee extensor muscles
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: CTRA group: rolling the contralateral muscles
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group: sitting for 6 minutes relaxed
Number of subjects: 27
Study: 35864718

Group type: EXPERIMENTAL
Intervention: CRRT with AN69-oXiris
Number of subjects: 16

Group type: COMPARATOR
Intervention: CRRT with AN69-ST
Number of subjects: 16
Study: 33992287

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neurodynamic Therapy (NDT)
Number of subjects: 60
Study: 32534221

Group type: EXPERIMENTAL
Intervention: Zoledronate 5 mg infusion
Number of subjects: 23
Study: 36052897

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of amiodarone diluted in 50 mL of 5% dextrose over 10 min
Number of subjects: 113

Group type: COMPARATOR
Intervention: 50 mL of 5% dextrose over 10 min
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 1 mg/kg of amiodarone
Number of subjects: 113

Group type: COMPARATOR
Intervention: 50 mL of 5% dextrose
Number of subjects: 113
Study: 34061406

Group type: EXPERIMENTAL
Intervention: Pre-grossing algorithm based on age, surgical approach, operation duration, biliary tract dilatation, and gallbladder gross anomalies
Number of subjects: 5663

Group type: COMPARATOR
Intervention: Control group (390 randomly selected cases)
Number of subjects: 5663
Study: 35511204

Group type: EXPERIMENTAL
Intervention: Cottonseed oil (CSO)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Olive oil (OO)
Number of subjects: 43
Study: 33441917

Group type: EXPERIMENTAL
Intervention: Lidocaine patch 5%
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (dressing retention tape only)
Number of subjects: 63
Study: 34605084

Group type: EXPERIMENTAL
Intervention: Multi-faceted early support model
Number of subjects: 83032

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 83032
Study: 34589083

Group type: EXPERIMENTAL
Intervention: BLXA4 oral rinse
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo rinse
Number of subjects: 127

Group type: COMPARATOR
Intervention: No-rinse control
Number of subjects: 127
Study: 34700571

Group type: EXPERIMENTAL
Intervention: 22-gene genomic classifier (GC) scores obtained from biopsy samples, assessed for distant metastases (DM), prostate cancer-specific mortality (PCSM), and overall survival (OS).
Number of subjects: 385

Group type: COMPARATOR
Intervention: 22-gene genomic classifier (GC) score ≥ 0.45 (intermediate/high GC) compared to low GC.
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: GC > 0.85 (threshold for inclusion in NRG GU009).
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: 22-gene genomic classifier (GC) scores in patients receiving short-term or long-term androgen-deprivation therapy (ADT).
Number of subjects: 385
Study: 35072987

Group type: EXPERIMENTAL
Intervention: Whole leaf spinach intake
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Minced spinach intake
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Spinach intake (both treatments)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no spinach intake)
Number of subjects: 19
Study: 33668740

Group type: EXPERIMENTAL
Intervention: Low-impulse-intensity group (LIG)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mid-impulse-intensity group (MIG)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High-impulse-intensity group (HIG)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 54
Study: 36215947

Group type: EXPERIMENTAL
Intervention: Vaccine + OPT-821
Number of subjects: 136

Group type: COMPARATOR
Intervention: OPT-821 alone
Number of subjects: 136
Study: 33323252

Group type: EXPERIMENTAL
Intervention: OL@‐OR@ mHealth programme (smartphone app and website)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Control version of the app (only collected baseline and outcome data)
Number of subjects: 726

Group type: EXPERIMENTAL
Intervention: OL@‐OR@ mHealth programme
Number of subjects: 726

Group type: COMPARATOR
Intervention: Control version of the app
Number of subjects: 726
Study: 35040959

Group type: EXPERIMENTAL
Intervention: JNJ‐64530440 750 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: JNJ‐64530440 750 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34224930

Group type: EXPERIMENTAL
Intervention: GA-PCA (general anaesthesia with morphine patient-controlled analgesia)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GA-LPB (general anaesthesia with lumbar plexus block)
Number of subjects: 18

Group type: COMPARATOR
Intervention: S-LPB (spinal anaesthesia with lumbar plexus block)
Number of subjects: 18
Study: 32824994

Group type: EXPERIMENTAL
Intervention: Poster with a story of a PSP who benefitted from ICBT
Number of subjects: 132

Group type: COMPARATOR
Intervention: Poster
Number of subjects: 132
Study: 36084645

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle therapy (energy restriction and exercise)
Number of subjects: 18
Study: 32797740

Group type: EXPERIMENTAL
Intervention: Single ProGlide suture-mediated vascular closure device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two ProGlide suture-mediated vascular closure devices
Number of subjects: 0
Study: 34647912

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 32669521

Group type: EXPERIMENTAL
Intervention: Verbascox® (800 mg/day) for 2 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg/day) for 2 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (watchful waiting)
Number of subjects: 150
Study: 35897439

Group type: EXPERIMENTAL
Intervention: Augmented Reality (AR) group
Number of subjects: 62

Group type: COMPARATOR
Intervention: Textbook group
Number of subjects: 62
Study: 32502908

Group type: EXPERIMENTAL
Intervention: 1 mA transcranial direct current stimulation (tDCS) to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 mA transcranial direct current stimulation (tDCS) to the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study: 33588150

Group type: EXPERIMENTAL
Intervention: Gem/afatinib (Gem: 1000 mg/m2 weekly for three weeks followed by one week of rest, repeated every four weeks; Afatinib: 40 mg orally once daily)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gem alone (1000 mg/m2 weekly for three weeks followed by one week of rest, repeated every four weeks)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Gem/afatinib
Number of subjects: 119

Group type: COMPARATOR
Intervention: Gem alone
Number of subjects: 119
Study: 33167909

Group type: EXPERIMENTAL
Intervention: Oxygen insufflation through the working channel during FOB intubation
Number of subjects: 36

Group type: COMPARATOR
Intervention: No oxygen insufflation during FOB intubation
Number of subjects: 36
Study: 36214868

Group type: EXPERIMENTAL
Intervention: Laparoscopic CME transhiatal approach (CEM-TH, n=61)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Traditional laparoscopic transhiatal (TH, n=38)
Number of subjects: 99
Study: 32945103

Group type: EXPERIMENTAL
Intervention: Physical health messages + self-monitoring
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Psychological health messages + self-monitoring
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 156

Group type: COMPARATOR
Intervention: No messages
Number of subjects: 156
Study: 34992255

Group type: EXPERIMENTAL
Intervention: 3-CTx (FOLFIRINOX) plus bevacizumab/cetuximab
Number of subjects: 256

Group type: COMPARATOR
Intervention: 2-CTx (FOLFOX or FOLFIRI) plus bevacizumab/cetuximab
Number of subjects: 256
Study: 35227132

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inactive resting
Number of subjects: 60
Study: 32949542

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg per month (with a 240 mg loading dose administered as two 120 mg injections) for 3 months
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 462

Group type: COMPARATOR
Intervention: Galcanezumab and Placebo
Number of subjects: 462
Study: 36288782

Group type: EXPERIMENTAL
Intervention: Dyson HEPA air purifier
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dummy filters (Placebo)
Number of subjects: 50
Study: 34487828

Group type: EXPERIMENTAL
Intervention: Medium protein (30%) diet
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High protein (35%) diet
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Low protein (25%) diet
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control diet (35%)
Number of subjects: 64
Study: 35940304

Group type: EXPERIMENTAL
Intervention: TOTIS e‐learning module
Number of subjects: 87
Study: 33068100

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Isometric Handgrip Training (IHG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Unilateral, upper limb remote ischaemic preconditioning (RIPC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-intervention control
Number of subjects: 48
Study: 35433976

Group type: EXPERIMENTAL
Intervention: Novel surgical guide using CBCT and gypsum model scan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Freehand surgery using only CBCT data
Number of subjects: 40
Study: 34372818

Group type: EXPERIMENTAL
Intervention: Combined group (IV + topical-TXA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: IV-TXA alone group
Number of subjects: 90
Study: 32677707

Group type: EXPERIMENTAL
Intervention: Remimazolam tosilate (RT)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 384
Study: 32371759

Group type: EXPERIMENTAL
Intervention: Lower SBP target (<130 mmHg)
Number of subjects: 1263

Group type: COMPARATOR
Intervention: Higher SBP target (130-149 mmHg)
Number of subjects: 1263